Get started
Author

Guido D. Pelaez

Observed names: Guido David Pelaez, Guido Pelaez
ORCID: 0009-0006-8449-8855
Observed ORCID: 0009-0006-8449-8855
OpenAlex ID: A5009411708
Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models
2020 · Satish Noonepalle, Sida Shen, et al. · Journal of Medicinal Chemistry · 55
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma
2025 · Edward R. Scheffer Cliff, Guido D. Pelaez, et al. · Clinical Cancer Research · 3
Development of Colonic Polyposis in a Woman With Chronic Myeloid Leukemia Treated With Dasatinib
2026 · Guido Pelaez, Behram Suha Yildiz, et al. · Case Reports in Hematology · 1
Allele-specific targeting of CD33 as a novel approach to enhance CAR-T selectivity in relapsed acute myeloid leukemia post–allogeneic transplantation.
2026 · Guido David Pelaez, Anthony Irovic, et al. · Journal of Clinical Oncology
Data from Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma
2026 · Edward R. Scheffer Cliff, Guido D. Pelaez, et al.
Supplemental Table 1 from Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma
2026 · Edward R. Scheffer Cliff, Guido D. Pelaez, et al.
Works count: 6
Citation count: 59
H-index: 2
I10-index: 1
Year
Topic
Type